With the rising burden of diseases, favourable government policies in the Asia-Pacific and the presence of strong developing economies in India, China and other countries in the region, companies are flocking to develop their presence and expand across the APAC.
This is where Asia Health, one of the leading medical products, services, and technology exhibition and congress, plays a key role. The free-to-attend event is set to take place at the Suntec Singapore Convention Centre, Singapore, from March 26 to 28 and brings together healthcare professionals from across the world. The event is well-known for being a must-attend exhibition for those who value the power of learning and networking, while doing business.
Offering over 200 product categories from 24 exhibiting countries and eight international pavilions, Asia Health is a one-stop-shop for all healthcare sourcing and procurement needs.
Furthermore, accompanying the exhibition are a number of business, leadership and Continuing Medical Education (CME) conferences and forums providing the very latest updates and insights in Patient Safety, Oncology and Healthcare Procurement. New for 2019, Asia Health will boast an array of both educational and innovative features and give special emphasis to topics such as Artificial Intelligence, Oncology, and Patient Safety.
This year, GE is a platinum sponsor of the event and also have a speaker taking part at the Oncology conference where the company will highlight its latest research. GE is well-known for its innovative solutions for oncology and supports cancer centres and hospitals all over the world to help improve cancer care from screening to treatment through advanced medical technologies, providing physicians and technicians with greater clinical insights. Over the years, the company’s solutions have helped improve the development of cell therapies, including CAR-T cell therapy. From stem cell recovery through separation and modification to expansion, harvesting, and testing, its functionally-closed systems and single-use solutions enable end-to-end production of cell therapies.
Plus, the Patient Safety & Quality Conference is being introduced at the event this year. Some of the key topics it will cover include reviewing the latest International Patient Safety Goals (IPSGs) and ways to implement them in the local medical practice setting; identifying strategies to achieve high-value healthcare to deliver top-tier quality service at the lowest cost, and identifying comprehensive solutions that ensure patient safety, risk, and quality activities are aligned with the strategic goals of the organisation.
The conference will also assess the current roles in patient safety to clarify responsibilities and reduce duplication of effort and discuss technology use to coordinate and streamline process changes, data collection, data analysis, monitoring, and evaluation.
The event will be co-located with MEDLAB Asia Pacific, which is in its sixth edition this year, and is one of Southeast Asia’s premier international laboratory and healthcare exhibitions. The 2019 edition of the event will host 15 CME-accredited conferences, eight international pavilions, over 200 product categories, and more than 250 exhibitors.
Fore more information visit www.medlabasia.com/asiahealth/en/home.html